CSF3 and neutropenia: The main focus of this survey was to evaluate the current practice of oncologists worldwide regarding the approach to chemotherapy-induced neutropenia with concerns about the administration of granulocyte colony-stimulating factors (G-CSF) and the impact of the current situation of the COVID-19 pandemic.